Sera Prognostics Inc (SERA NASDAQ) stock market data APIs
$3.1162
0.07(2.2%)
as of September 15, 2025
Try our APIs with
free plan!
Sera Prognostics Inc Financial Data Overview
Price chart is built with
Anychart
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Prev. Close
3.1162
Open
3.1891
High
3.2474
Low
2.9838
52 wk Range
1.37-9.1297
Market Cap
118 M
Shares Outstanding
37 094 K
Revenue
108 K
EPS
-0.16
Beta
1
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sera Prognostics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sera Prognostics Inc data using free add-ons & libraries
Get Sera Prognostics Inc Fundamental Data
Sera Prognostics Inc Fundamental data includes:
- Net Revenue: 108 K
- EBITDA: -36 067 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.23
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sera Prognostics Inc News
New
Sera Prognostics outlines European expansion and new commercial hires while targeting PreTRM Test reimbursement pilots
Earnings Call Insights: Sera Prognostics (SERA) Q2 2025 MANAGEMENT VIEW * President and CEO Evguenia Lindgardt stated that "we're continuing to advance Sera's commercial progress and building mome...
Sera Prognostics Inc-A (NASDAQ:SERA) Reports Mixed Q2 2025 Results: EPS Beat Offsets Revenue Miss
SERA PROGNOSTICS INC-A (NASDAQ:SERA [https://www.chartmill.com/stock/quote/SERA/profile]) REPORTS Q2 2025 EARNINGS: REVENUE MISSES, EPS BEATS ESTIMATES Sera Prognostics Inc., a company specializing i...
Insider Sale: Chief Financial Officer of $SERA Sells 945 Shares
Austin Aerts, the Chief Financial Officer of $SERA, sold 945 shares of the company on 06-10-2025 for an estimated $1,398. We received data on the trade from a recent SEC filing. This was a sale of app...
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
SALT LAKE CITY, March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
